Thymia Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $6.39M

  • Investors
  • 14

Thymia General Information

Description

Developer of video games designed to make mental health as objectively measurable as physical health. The company's platform uses video games based on neuropsychology alongside analyses of video and speech to make mental health assessments, offering a multi-modal depression recognition and tracking system that allows for rapid treatment decisions, enabling clinicians to assess depression more accurately and objectively.

Contact Information

Website
www.thymia.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • International House
  • 64 Nile Street
  • London N1 7SR
  • England, United Kingdom
Primary Industry
Other Healthcare Technology Systems
Vertical(s)
LOHAS & Wellness, Digital Health, Artificial Intelligence & Machine Learning, Gaming, HealthTech
Corporate Office
  • International House
  • 64 Nile Street
  • London N1 7SR
  • England, United Kingdom

Thymia Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Thymia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 07-Oct-2024 $6.39M Completed Generating Revenue
8. Accelerator/Incubator 01-Jul-2024 Completed Generating Revenue
7. Accelerator/Incubator 01-May-2024 Completed Generating Revenue
6. Accelerator/Incubator 09-Nov-2023 Completed Generating Revenue
5. Seed Round 27-May-2023 Completed Generating Revenue
4. Grant 01-Nov-2022 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
2. Seed Round 21-Apr-2021 $1.07M $1.12M Completed Generating Revenue
1. Accelerator/Incubator 23-Jul-2020 $50.1K $50.1K Completed Startup
To view Thymia’s complete valuation and funding history, request access »

Thymia Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed Preferred 2
Ordinary
Ordinary
Seed Preferred
Seed Preferred
Ordinary
Pre Seed Preferred
Pre Seed Preferred
Ordinary 30,477 $0.000132 $4.51 $4.51 1x $4.51 1.57%
Ordinary 20,000 $0.000132 $2.65 $2.65 1x $2.65 1.03%
To view Thymia’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Thymia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of video games designed to make mental health as objectively measurable as physical health. The company's plat
Other Healthcare Technology Systems
London, United Kingdom
31 As of 2025

Boston, MA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Thymia Competitors (4)

One of Thymia’s 4 competitors is Sonde, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sonde Venture Capital-Backed Boston, MA
Youper Venture Capital-Backed San Francisco, CA
Aiberry Venture Capital-Backed Bellevue, WA
Woebot Health Venture Capital-Backed San Francisco, CA
To view Thymia’s complete competitors history, request access »

Thymia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Thymia Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Texas Medical Center Venture Capital Minority
DigitalHealth.London Accelerator Accelerator/Incubator
Grow London Accelerator/Incubator
UCB Corporation
Angel (individual) Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Thymia FAQs

  • When was Thymia founded?

    Thymia was founded in 2020.

  • Where is Thymia headquartered?

    Thymia is headquartered in London, United Kingdom.

  • What is the size of Thymia?

    Thymia has 31 total employees.

  • What industry is Thymia in?

    Thymia’s primary industry is Other Healthcare Technology Systems.

  • Is Thymia a private or public company?

    Thymia is a Private company.

  • What is the current valuation of Thymia?

    The current valuation of Thymia is .

  • What is Thymia’s current revenue?

    The current revenue for Thymia is .

  • How much funding has Thymia raised over time?

    Thymia has raised $10.4M.

  • Who are Thymia’s investors?

    Texas Medical Center, DigitalHealth.London Accelerator, Grow London, UCB, and are 5 of 14 investors who have invested in Thymia.

  • Who are Thymia’s competitors?

    Sonde, Youper, Aiberry, and Woebot Health are competitors of Thymia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »